Glyceryl trinitrate for the treatment of preterm labor
Özet
Objective: This study was conducted to compare the tocolytic efficacy of glyceryltrinitrate (GTN) with that of magnesium sulfate (MgSO4) and to investigate serum nitric oxide metabolites before and after tocolysis. Material and Methods: In total, 48 women between 27 and 34 weeks’ gestation with threatened preterm labor and intact membranes were randomly allocated to receive either GTN or MgSO4 tocolysis. Main outcome measures included tocolytic efficacy and maternal side effect(s) of the tocolytic agent. Obstetric and neonatal outcomes as well as pretreatment and posttreatment nitric oxide (NO) metabolites were assessed. Results: Forty-one patients were included into the final analysis. Uterine contraction cessation times were 3.66±1.28 and 6.83±3.47 hours for GTN and MgSO4 groups, respectively. Similarly, maternal side effects were significantly lower in the GTN group than in the MgSO4 group, and no serious maternal side effects were recorded. Serum NO metabolite levels before treatment were significantly lower in the treatment groups than in the controls. Serum nitrite levels were significantly increased after tocolytic treatment both in MgSO4 and GTN groups. Conclusion: GTN effectively delays preterm delivery and reduces neonatal morbidity and mortality with less maternal side effects and seems to be an effective and safe alternative to MgSO4. © 2015 by the Turkish-German Gynecological Education and Research Foundation.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Çalışkan, Şafak | |
| dc.contributor.author | Narin, Mehmet Ali | |
| dc.contributor.author | Dede, Faruk Suat | |
| dc.contributor.author | Narin, Raziye | |
| dc.contributor.author | Dede, Hülya | |
| dc.contributor.author | Kandemir, Ömer | |
| dc.date.accessioned | 2026-10-18T20:29:57.299206546Z | |
| dc.date.available | 2026-10-18T20:29:57.299206546Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Objective: This study was conducted to compare the tocolytic efficacy of glyceryltrinitrate (GTN) with that of magnesium sulfate (MgSO4) and to investigate serum nitric oxide metabolites before and after tocolysis. Material and Methods: In total, 48 women between 27 and 34 weeks’ gestation with threatened preterm labor and intact membranes were randomly allocated to receive either GTN or MgSO4 tocolysis. Main outcome measures included tocolytic efficacy and maternal side effect(s) of the tocolytic agent. Obstetric and neonatal outcomes as well as pretreatment and posttreatment nitric oxide (NO) metabolites were assessed. Results: Forty-one patients were included into the final analysis. Uterine contraction cessation times were 3.66±1.28 and 6.83±3.47 hours for GTN and MgSO4 groups, respectively. Similarly, maternal side effects were significantly lower in the GTN group than in the MgSO4 group, and no serious maternal side effects were recorded. Serum NO metabolite levels before treatment were significantly lower in the treatment groups than in the controls. Serum nitrite levels were significantly increased after tocolytic treatment both in MgSO4 and GTN groups. Conclusion: GTN effectively delays preterm delivery and reduces neonatal morbidity and mortality with less maternal side effects and seems to be an effective and safe alternative to MgSO4. © 2015 by the Turkish-German Gynecological Education and Research Foundation. | |
| dc.identifier.doi | 10.5152/jtgga.2015.15016 | |
| dc.identifier.eissn | 1309-0380 | |
| dc.identifier.endpage | 178 | |
| dc.identifier.issn | 1309-0399 | |
| dc.identifier.issue | 3 | |
| dc.identifier.pmcid | PMC4560476 | |
| dc.identifier.pmid | 26401112 | |
| dc.identifier.scopus | 2-s2.0-84940210129 | |
| dc.identifier.startpage | 174 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/15163 | |
| dc.identifier.volume | 16 | |
| dc.identifier.wos | WOS:000360154900009 | |
| dc.language.iso | en | |
| dc.publisher | AVES | |
| dc.relation.ispartof | Journal of the Turkish German Gynecology Association | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Glyceryl trinitrate | |
| dc.subject | Magnesium sulfate | |
| dc.subject | Nitric oxide | |
| dc.subject | Tocolysis | |
| dc.subject | betamethasone acetate plus betamethasone sodium phosphate | |
| dc.subject | diazepam | |
| dc.subject | paracetamol | |
| dc.subject | adult | |
| dc.subject | Article | |
| dc.subject | body temperature disorder | |
| dc.subject | clinical article | |
| dc.subject | clinical effectiveness | |
| dc.subject | controlled study | |
| dc.subject | dizziness | |
| dc.subject | drug safety | |
| dc.subject | female | |
| dc.subject | gestation period | |
| dc.subject | headache | |
| dc.subject | heart palpitation | |
| dc.subject | human | |
| dc.subject | loading drug dose | |
| dc.subject | nausea | |
| dc.subject | newborn morbidity | |
| dc.subject | newborn mortality | |
| dc.subject | outcome assessment | |
| dc.subject | pregnancy outcome | |
| dc.subject | premature labor | |
| dc.subject | prospective study | |
| dc.subject | protein blood level | |
| dc.subject | randomized controlled trial | |
| dc.title | Glyceryl trinitrate for the treatment of preterm labor | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 3 | |
| rdl.citation.wos | 2 | |
| rdl.department | Department of Obstetrics and Gynecology, Erzincan University Faculty of Medicine, Erzincan, Turkey. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Emerging Sources Citation Index (ESCI) |
